Pinatuzumab vedotin | CD markers inhibitor | Read Reviews & Product Use Citations

Pinatuzumab Vedotin (RG-7593, DCDT2980S, DCDT-2989S), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker.

CAS No. 1313706-14-7

Click to purchase products related to Pinatuzumab vedotin

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Pinatuzumab Vedotin (RG-7593, DCDT2980S, DCDT-2989S), is an antibody-drug conjugate (ADC) composed of CD22 (Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14) antibody and cytotoxic agent monomethyl auristatin E (MMAE) conjugated through maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker.

References
[1] Advani RH, et al. Clin Cancer Res. 2017 Mar 1;23(5):1167-1176.

References

[1] Advani RH, et al. Clin Cancer Res. 2017 Mar 1;23(5):1167-1176.

Product Details

CAS No.	1313706-14-7
ADC antiody	Pinatuzumab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field